Kim to head pharmaceutical group

Published: 2012-04-03 06:56:00

Updated: 2012-04-03 06:56:00

Kim Dae-joong, CEO of Daiichi-Sankyo Korea, was elected president of the Korea Japanese Pharmaceutical Association (KJPA) as of March 13, the association said.

Kim will replace incumbent Hukuyama Mashashi, CEO of Daiichi-Kirin Pharma, who is scheduled to return to the headquarters in Tokyo nex...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK